Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.

Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2011 Apr;26(4):792-802. doi: 10.1002/jbmr.272.

2.

Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.

Wang T, Wang Y, Menendez A, Fong C, Babey M, Tahimic CG, Cheng Z, Li A, Chang W, Bikle DD.

J Bone Miner Res. 2015 Sep;30(9):1572-84. doi: 10.1002/jbmr.2510.

3.

Low-dose X-ray irradiation promotes osteoblast proliferation, differentiation and fracture healing.

Chen M, Huang Q, Xu W, She C, Xie ZG, Mao YT, Dong QR, Ling M.

PLoS One. 2014 Aug 4;9(8):e104016. doi: 10.1371/journal.pone.0104016. eCollection 2014.

4.

Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.

Choudhary S, Blackwell K, Voznesensky O, Deb Roy A, Pilbeam C.

Bone. 2013 Sep;56(1):31-41. doi: 10.1016/j.bone.2013.04.017. Epub 2013 Apr 29.

5.

PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy Metabolism.

Feigenson M, Eliseev RA, Jonason JH, Mills BN, O'Keefe RJ.

J Cell Biochem. 2017 Dec;118(12):4383-4393. doi: 10.1002/jcb.26092. Epub 2017 May 31.

PMID:
28444901
6.

SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.

Tsujisawa T, Inoue H, Nishihara T.

J Bone Miner Res. 2005 Jan;20(1):15-22. Epub 2004 Oct 18.

7.

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.

Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T.

Endocrinology. 2000 Apr;141(4):1554-9.

PMID:
10746663
8.

Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.

Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, Pan LC, Brown TA, Thompson DD.

Bone. 2005 Jul;37(1):46-54.

PMID:
15869929
9.

A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.

Carroll SH, Wigner NA, Kulkarni N, Johnston-Cox H, Gerstenfeld LC, Ravid K.

J Biol Chem. 2012 May 4;287(19):15718-27. doi: 10.1074/jbc.M112.344994. Epub 2012 Mar 8.

10.

Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.

Sanuki R, Shionome C, Kuwabara A, Mitsui N, Koyama Y, Suzuki N, Zhang F, Shimizu N, Maeno M.

Connect Tissue Res. 2010 Apr;51(2):150-8. doi: 10.3109/03008200903168484.

PMID:
20001844
11.

Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.

Xie C, Liang B, Xue M, Lin AS, Loiselle A, Schwarz EM, Guldberg RE, O'Keefe RJ, Zhang X.

Am J Pathol. 2009 Aug;175(2):772-85. doi: 10.2353/ajpath.2009.081099. Epub 2009 Jul 23.

12.

Exogenous PTHrP Repairs the Damaged Fracture Healing of PTHrP+/- Mice and Accelerates Fracture Healing of Wild Mice.

Wang Y, Fang X, Wang C, Ding C, Lin H, Liu A, Wang L, Cao Y.

Int J Mol Sci. 2017 Feb 6;18(2). pii: E337. doi: 10.3390/ijms18020337.

13.

Reduced COX-2 expression in aged mice is associated with impaired fracture healing.

Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JE, Boyce B, Zhang X, O'Keefe RJ.

J Bone Miner Res. 2009 Feb;24(2):251-64. doi: 10.1359/jbmr.081002.

14.

Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.

Wang YH, Qiu Y, Han XD, Xiong J, Chen YX, Shi HF, Karaplis A.

Clin Exp Pharmacol Physiol. 2013 Nov;40(11):715-23. doi: 10.1111/1440-1681.12161.

PMID:
23937065
15.

Loss of Smad3 gives rise to poor soft callus formation and accelerates early fracture healing.

Kawakatsu M, Kanno S, Gui T, Gai Z, Itoh S, Tanishima H, Oikawa K, Muragaki Y.

Exp Mol Pathol. 2011 Feb;90(1):107-15. doi: 10.1016/j.yexmp.2010.10.011. Epub 2010 Oct 28.

PMID:
21035443
16.

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro.

Tomita M, Li X, Okada Y, Woodiel FN, Young RN, Pilbeam CC, Raisz LG.

Bone. 2002 Jan;30(1):159-63. Erratum in: Bone. 2003 Jun;32(6):725.

PMID:
11792579
17.

Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.

Alam I, Alkhouli M, Gerard-O'Riley RL, Wright WB, Acton D, Gray AK, Patel B, Reilly AM, Lim KE, Robling AG, Econs MJ.

Endocrinology. 2016 Feb;157(2):722-36. doi: 10.1210/en.2015-1281. Epub 2015 Nov 19.

18.

Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing.

Dishowitz MI, Mutyaba PL, Takacs JD, Barr AM, Engiles JB, Ahn J, Hankenson KD.

PLoS One. 2013 Jul 3;8(7):e68726. doi: 10.1371/journal.pone.0068726. Print 2013.

19.

Obesity does not affect the healing of femur fractures in mice.

Histing T, Andonyan A, Klein M, Scheuer C, Stenger D, Holstein JH, Veith NT, Pohlemann T, Menger MD.

Injury. 2016 Jul;47(7):1435-44. doi: 10.1016/j.injury.2016.04.030. Epub 2016 Apr 23.

PMID:
27156834
20.

Coenzyme q10 regulates osteoclast and osteoblast differentiation.

Moon HJ, Ko WK, Jung MS, Kim JH, Lee WJ, Park KS, Heo JK, Bang JB, Kwon IK.

J Food Sci. 2013 May;78(5):H785-891. doi: 10.1111/1750-3841.12116. Epub 2013 Apr 12.

PMID:
23582186

Supplemental Content

Support Center